Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Rubens

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pediatric Reviews|December 17, 2016
Five Pediatric Cancers - Update on Genetic ImplicationsStacy Cooper, Jeffrey Rubens, Joann Bodurtha
Pediatric Blood & Cancer|June 15, 2011
Long-term survival in a pediatric patient with supratentorial primitive neuro-ectodermal tumor and extraneural metastasis at diagnosisJeffrey Rubens, Yasmin Gosiengfiao, Tadanori Tomita, et al.
Journal of Neuropathology and Experimental Neurology|May 31, 2020
MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid TumorsShubin Shahab, Jeffrey Rubens, Harpreet Kaur, et al.
Neoplasia (New York, N.Y.)|February 11, 2023
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumorElizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mirdametinib and abemaciclib cooperate in atypical teratoid rhabdoid tumor to decrease proliferation and suppress tumor growthJinming Liang, Yiming Deng, Anupa Geethadevi, et al.
Neuro-Oncology|December 1, 2020
Conditional reprogramming culture conditions facilitate growth of lower-grade glioma modelsMing Yuan, David White, Linda Resar, et al.
Lymphatic Research and Biology|December 31, 2004
Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involutionMatthew R Ritter, Stacey K Moreno, Michael I Dorrell, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft modelsAnupa Geethadevi, Nikhil Vaidya, Robert J Fisher, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Oncotarget|February 2, 2015
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie F Weingart, Jacquelyn J Roth, Marianne Hutt-Cabezas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pediatric Reviews|December 17, 2016
Five Pediatric Cancers - Update on Genetic ImplicationsStacy Cooper, Jeffrey Rubens, Joann Bodurtha
Pediatric Blood & Cancer|June 15, 2011
Long-term survival in a pediatric patient with supratentorial primitive neuro-ectodermal tumor and extraneural metastasis at diagnosisJeffrey Rubens, Yasmin Gosiengfiao, Tadanori Tomita, et al.
Journal of Neuropathology and Experimental Neurology|May 31, 2020
MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid TumorsShubin Shahab, Jeffrey Rubens, Harpreet Kaur, et al.
Neoplasia (New York, N.Y.)|February 11, 2023
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumorElizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mirdametinib and abemaciclib cooperate in atypical teratoid rhabdoid tumor to decrease proliferation and suppress tumor growthJinming Liang, Yiming Deng, Anupa Geethadevi, et al.
Neuro-Oncology|December 1, 2020
Conditional reprogramming culture conditions facilitate growth of lower-grade glioma modelsMing Yuan, David White, Linda Resar, et al.
Lymphatic Research and Biology|December 31, 2004
Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involutionMatthew R Ritter, Stacey K Moreno, Michael I Dorrell, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft modelsAnupa Geethadevi, Nikhil Vaidya, Robert J Fisher, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Oncotarget|February 2, 2015
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie F Weingart, Jacquelyn J Roth, Marianne Hutt-Cabezas, et al.
Pageof 1